Skip to main content

Table 3 description of the three clusters identified by CMA and AHC

From: Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods

Clusters, N = 38

P value

Cluster A, N = 16

 Educational level: college

0.0003

 Actual of former profession: executive

0.048

 Reason for discontinuation: disease progression

0.002

 Length of oral chemotherapy ≤3 cycles

0.003

 Intention to get more information elsewhere

0.02

 Thought a dose could be missed during treatment

0.02

 In couple with children

0.049

Cluster B, N = 9

 Occupation: retired

<0.0001

 Educational level: primary school

0.0001

 Thought that missing a dose was serious

0.02

 BMI <28

0.042

Cluster C, N = 13

 Educational level: secondary school

0.003

 No discontinuation of protocol

0.004

 Length of oral chemotherapy ≥3 cycles

0.014

 Did not know the prescribed dose well

0.009

 Occupation: sick leave

0.01

 Residence: town

0.03

 Did not think that a dose could be missed during treatment

0.03

 Already had had oral chemotherapy

0.04

 Did not know there was a choice between oral/IV treatment

0.04